{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:21:12Z","timestamp":1773800472665,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psychotic symptoms associated with hypothyroidism, also known as \u201cmyxedema psychosis,\u201d are a treatable cause of psychosis often associated with complete recovery. While most cases receive both thyroxine and a short course of antipsychotics, some reports indicate that symptoms can resolve without antipsychotic treatment, though follow-up in these cases has often been short or not reported. This is one of the first case reports demonstrating sustained remission of psychotic symptoms at 6\u00a0months in a case of myxedema psychosis treated with minimal antipsychotic medication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe the case of a 40-year-old Caucasian woman who was brought to hospital with a 7-day history of anxiety and decreased sleep and 1\u00a0day of disorganized speech, paranoid delusions, and auditory hallucinations. After being admitted to psychiatry for management, screening blood work revealed elevated thyroid-stimulating hormone. The patient was initiated on treatment with levothyroxine and low doses of antipsychotics. Her symptoms resolved on the third day of her admission with ongoing symptomatic remission at 6\u00a0months follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The identification of myxedema psychosis is important owing to the implications on treatment and prognosis of the disorder. Our case suggests that sustained symptom resolution may occur with little to no antipsychotic treatment, though these findings are preliminary and additional study is needed before definitive conclusions on the optimal approach can be made.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03626-x","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:04:09Z","timestamp":1666224249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sustained remission of psychotic symptoms secondary to hypothyroidism (myxedema psychosis) after 6\u00a0months of treatment primarily with levothyroxine: a case report"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5507-263X","authenticated-orcid":false,"given":"Eric C.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"3626_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/bmj.2.4627.555","volume":"2","author":"R Asher","year":"1949","unstructured":"Asher R. Myxoedematous madness. Br Med J. 1949;2:555\u201362.","journal-title":"Br Med J"},{"key":"3626_CR2","first-page":"2713","volume":"17","author":"MF Mohamed","year":"2021","unstructured":"Mohamed MF, Danjuma M, Mohammed M, Mohamed S, Siepmann M, Barlinn K. Myxedema psychosis: systematic review and pooled analysis. Neuropsychiatr Dis Treat. 2021;17:2713\u201328.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3626_CR3","unstructured":"Natarajan MN. Hypothyroidism presenting as psychosis\u2014a case report. Univ J Med Med Specialities. 2020. http:\/\/ejournal-tnmgrmu.ac.in\/index.php\/medicine\/article\/view\/11655."},{"issue":"6","key":"3626_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.5664\/jcsm.2274","volume":"8","author":"JM Neal","year":"2012","unstructured":"Neal JM, Yuhico RJO. \u201cMyxedema madness\u201d associated with newly diagnosed hypothyroidism and obstructive sleep apnea. J Clin Sleep Med. 2012;8(6):717\u20138. https:\/\/doi.org\/10.5664\/jcsm.2274.","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"3626_CR5","first-page":"135","volume":"51","author":"JM Nielsen","year":"2010","unstructured":"Nielsen JM. I see dead people. Hypothyroid myopathy and hypothyroid psychosis. J Miss State Med Assoc. 2010;51(5):135\u20136.","journal-title":"J Miss State Med Assoc"},{"issue":"9","key":"3626_CR6","first-page":"S527","volume":"61","author":"KS Reddy","year":"2019","unstructured":"Reddy KS, Rao GP. Hypothyroidism presenting as acute mania\u2014rare case report. Indian J Psychiatry. 2019;61(9):S527\u20139.","journal-title":"Indian J Psychiatry."},{"issue":"4","key":"3626_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4088\/pcc.v10n0411a","volume":"10","author":"V Selvaraj","year":"2008","unstructured":"Selvaraj V, Padala PR. Thyroid myopathy with rhabdomyolysis presenting as agitation: a case report. Prim Care Companion J Clin Psychiatry. 2008;10(4):328. https:\/\/doi.org\/10.4088\/pcc.v10n0411a.","journal-title":"Prim Care Companion J Clin Psychiatry."},{"key":"3626_CR8","first-page":"35","volume-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","author":"GA Keepers","year":"2021","unstructured":"Keepers GA, Fochtmann LJ, Anzia JM, Benjamin S, Lyness JM, Mojtabai R, et\u00a0al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. 3rd ed. Washington, DC: American Psychiatric Association; 2021. p. 35\u20139.","edition":"3"},{"key":"3626_CR9","first-page":"81","volume-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","author":"GA Keepers","year":"2021","unstructured":"Keepers GA, Fochtmann LJ, Anzia JM, Benjamin S, Lyness JM, Mojtabai R, et\u00a0al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. 3rd ed. Washington, DC: American Psychiatric Association; 2021. p. 81.","edition":"3"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03626-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:05:56Z","timestamp":1666224356000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03626-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3626"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03626-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he has no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}